These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4699003)

  • 1. Product dissolution methods.
    Leeson LJ
    J Pharm Sci; 1973 Apr; 62(4):IV. PubMed ID: 4699003
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization and establishment of specifications for biopharmaceuticals.
    Davis GC; Riggin RM
    Dev Biol Stand; 1997; 91():49-54. PubMed ID: 9413683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specifications from a biotechnology industry perspective.
    Garnick RL
    Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of specifications for biotechnology products--perspective from Europe.
    Trouvin JH
    Dev Biol Stand; 1997; 91():25-30. PubMed ID: 9413679
    [No Abstract]   [Full Text] [Related]  

  • 5. Global perspective on specifications for biotechnology products--perspective from Japan.
    Hayakawa T
    Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro - in vivo correlation: from theory to applications.
    Emami J
    J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.
    Dokoumetzidis A; Macheras P
    Int J Pharm; 2006 Sep; 321(1-2):1-11. PubMed ID: 16920290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): theoretical basis and practical examples.
    Papadopoulou V; Valsami G; Dokoumetzidis A; Macheras P
    Int J Pharm; 2008 Sep; 361(1-2):70-7. PubMed ID: 18614303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dissolution tests for oral formulas containing active principles slightly soluble in water].
    Bertolotti F; De Leo S; Fontani F; Sekules G
    Boll Chim Farm; 1973 Mar; 112(3):163-9. PubMed ID: 4721640
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug product quality.
    J Am Pharm Assoc; 1970 Feb; 10(2):107-16. PubMed ID: 5411068
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of physiologically relevant biopharmaceutics tools within the pharmaceutical industry and in regulatory sciences: Where are we now and what are the gaps?
    Flanagan T; Van Peer A; Lindahl A
    Eur J Pharm Sci; 2016 Aug; 91():84-90. PubMed ID: 27283487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary Report.
    Mitra A; Suarez-Sharp S; Pepin XJH; Flanagan T; Zhao Y; Kotzagiorgis E; Parrott N; Sharan S; Tistaert C; Heimbach T; Zolnik B; Sjögren E; Wu F; Anand O; Kakar S; Li M; Veerasingham S; Kijima S; Lima Santos GM; Ning B; Raines K; Rullo G; Mandula H; Delvadia P; Dressman J; Dickinson PA; Babiskin A
    J Pharm Sci; 2021 Feb; 110(2):594-609. PubMed ID: 33152375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA perspective on specifications for biotechnology products--from IND to PLA.
    Murano G
    Dev Biol Stand; 1997; 91():3-13. PubMed ID: 9413677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro drug release rate as a standard requirement.
    Láng B
    Pharmazie; 1971 Nov; 26(11):661-4. PubMed ID: 5154319
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceutical industry.
    Weiner M
    Pharmacology; 1972; 8(1):201-4. PubMed ID: 4644649
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 17. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.
    Lindenberg M; Kopp S; Dressman JB
    Eur J Pharm Biopharm; 2004 Sep; 58(2):265-78. PubMed ID: 15296954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parenteral suspensions.
    Nash RA
    Bull Parenter Drug Assoc; 1972; 26(2):91-4. PubMed ID: 5012208
    [No Abstract]   [Full Text] [Related]  

  • 19. Quality control of pharmaceutical preparations and the Third World.
    Summers RS
    Cent Afr J Med; 1983 Dec; 29(12):247-9. PubMed ID: 6671214
    [No Abstract]   [Full Text] [Related]  

  • 20. [How to assure the quality of a medicinal product ].
    Agosti ME
    Medicina (B Aires); 2003; 63(5):450-2. PubMed ID: 14628657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.